Barry J. Simon, Director at ImmunityBio, Inc. (IBRX), sold 25,000 shares at $10.75 ($269K) on 2026-10-05, disclosed to the SEC on 2026-10-06.
Scheduled sale ($269k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| IBRX | SELL | 2026-02-26 | $1.8M | — | Filing → |
| IBRX | SELL | 2026-02-24 | $3.5M | — | Filing → |
| IBRX | SELL | 2026-01-21 | $1.1M | — | Filing → |